STOCK TITAN

EARTH SCIENCE TECH (ETST) Stock Price, News & Analysis

ETST OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
100 247 sessions, October 2, 2025 to October 2, 2026
Largest daily move
+46.3% close of October 31, 2025
1-year change
-50.8% closing prices, October 2, 2025 to October 2, 2026
1-month change
+3.5% closing prices, September 1, 2026 to October 2, 2026

Company Description

Earth Science Tech, Inc. (ETST) is a Florida-based public company that operates as a strategic holding company, with a focus on healthcare and pharmaceutical operations. According to its SEC classification and company disclosures, Earth Science Tech is formally identified under SIC code 2834 for pharmaceutical preparations and has transitioned away from legacy CBD and cannabis-related activities. The company’s common stock, with a par value of $0.001, trades on the Over the Counter Bulletin Board under the ticker symbol ETST.

Earth Science Tech centers its business model on acquiring, optimizing, and managing operating businesses. The company describes its mission as value creation through acquisition, operational optimization, and management of subsidiaries. Its current operations span compounding pharmaceuticals, telemedicine, and real estate development, as well as consumer brands, through a portfolio of wholly owned and majority-owned entities.

Healthcare and Pharmaceutical Operations

A core pillar of Earth Science Tech’s strategy is its healthcare and pharmaceutical platform. The company states that it operates within the healthcare and pharmaceutical sectors and that its operations are aligned with its SIC 2834 classification.

  • RxCompoundStore.com, LLC – A fully licensed compounding pharmacy based in Miami, Florida. Company disclosures note that RxCompoundStore.com is authorized to fulfill prescriptions in multiple U.S. states and Puerto Rico, and that it is actively pursuing licensure in remaining states.
  • Mister Meds, LLC (Mister Meds) – A pharmacy located in Abilene, Texas. The company reports that Mister Meds received full compounding licensure and operates from a facility owned by Avenvi, with advanced sterile compounding capabilities, including positive and negative pressure environments and hazardous drug handling. Mister Meds is described as applying for licensure in states not yet serviced by RxCompoundStore.com.
  • Peaks Curative, LLC – A telemedicine referral platform that offers asynchronous consultations for Peaks-branded compounded medications prepared at RxCompoundStore.com and Mister Meds. The platform operates in states where either pharmacy is licensed and is supported by a developing healthcare provider network under MyOnlineConsultation.com.
  • Las Villas Health Care, Inc. – A brick-and-mortar healthcare facility dedicated to the Spanish-speaking community. Company descriptions highlight advanced sexual health treatments and customized solutions aimed at enhancing physical performance, with an emphasis on personalized care and patient education.
  • DOConsultations, LLC – A telehealth-focused business described as modernizing the availability and delivery of home therapies. According to Earth Science Tech, DOConsultations providers tailor medication plans around patient health and wellness goals and coordinate with partner pharmacies that ship medications directly to patients.

Through these subsidiaries, Earth Science Tech connects compounding pharmacies with telemedicine platforms and in-person care, creating an integrated healthcare ecosystem that manages both the preparation and clinical delivery of pharmaceutical products, as described in its news releases.

Real Estate and Infrastructure via Avenvi

Avenvi, LLC is identified by Earth Science Tech as a diversified real estate company engaged in development, asset management, and financing. Company statements indicate that Avenvi maintains a growing portfolio of real estate holdings and provides turnkey solutions from development to end-user financing. Avenvi also manages investment activities for Earth Science Tech and oversees the company’s share repurchase program, which has been expanded over time according to multiple news releases.

In addition to its development activities, Avenvi owns the real estate property where Mister Meds operates, highlighting the link between the company’s real estate and healthcare operations. Disclosures also note that Avenvi has begun work on residential development projects, reflecting its role in supporting the broader holding company structure.

Consumer Brands and Intellectual Property

Beyond healthcare and real estate, Earth Science Tech holds an interest in consumer-facing brands built around intellectual property:

  • MagneChef – Described as a direct-to-consumer retail brand that utilizes patents and intellectual properties to develop products marketed and sold online. Company materials state that MagneChef has developed products for cooking and is working to expand its product line with new offerings that incorporate its intellectual property. Earth Science Tech reports an 80% ownership interest in MagneChef.
  • In more recent disclosures, MagneChef is also said to have expanded into the premium American-made BBQ tool brand market through the acquisition of BBQraft, further extending the consumer product focus built on proprietary designs.

Strategic Holding Company Model

Across its portfolio, Earth Science Tech emphasizes a strategy of acquiring and scaling high-potential operating businesses. The company repeatedly characterizes itself as a strategic holding company focused on:

  • Acquisition of operating businesses in healthcare, telemedicine, real estate, and consumer products.
  • Operational optimization, including governance, cross-subsidiary coordination, and efficiency improvements.
  • Long-term value creation through active management of its subsidiaries.

Company communications describe a shift from acquisition-focused activity to maximizing the value and profitability of existing divisions, particularly within its healthcare and pharmacy operations.

Regulatory Status and Market Positioning

Earth Science Tech has highlighted several regulatory and market milestones in its public disclosures:

  • The company notes that its primary SIC code is 2834 (Pharmaceutical Preparations) and that it has formally identified as a pharmaceutical entity since 2022.
  • It reports that FINRA processed a Form 211 relating to the initiation of priced quotations of ETST, which the company describes as a critical step in its strategic plan.
  • Earth Science Tech has also announced qualification for and listing on the OTCID tier of the OTC Markets, a tier that recognizes companies meeting enhanced disclosure and transparency standards, according to its news release.

In multiple communications, the company states that it is actively working with data providers and financial platforms to ensure that its classification as a healthcare and pharmaceutical-focused entity is accurately reflected, replacing outdated references to CBD or cannabis-related activities.

Capital Allocation and Share Structure Actions

Earth Science Tech has disclosed several actions related to capital allocation and share structure:

  • Share Repurchase Program – The company has announced a common stock repurchase program, with authorization levels that have been increased over time. Avenvi is described as overseeing this program on behalf of Earth Science Tech.
  • Reduction of Authorized Shares – Through an amendment to its Articles of Incorporation filed in Florida, Earth Science Tech reduced its authorized common stock from 350,000,000 shares to 300,000,000 shares. The amendment was approved via majority shareholder written consent and a corporate resolution, as detailed in an 8-K filing.

These measures are presented by the company as aligned with its focus on shareholder value and its broader strategic trajectory.

Subsidiary Overview

Based on company disclosures and repeated descriptions in news releases, Earth Science Tech’s operating structure includes:

  • RxCompoundStore.com, LLC – Compounding pharmacy.
  • Mister Meds, LLC – Compounding pharmacy with advanced sterile capabilities.
  • Peaks Curative, LLC – Telemedicine referral platform.
  • Las Villas Health Care, Inc. – Brick-and-mortar healthcare facility serving the Spanish-speaking community.
  • DOConsultations, LLC – Telehealth and home-therapy-focused provider coordination platform.
  • Avenvi, LLC – Real estate development, asset management, and financing business that also manages investment activities and the share repurchase program.
  • Earth Science Foundation, Inc. – Identified as a subsidiary in company descriptions.
  • MagneChef – Direct-to-consumer retail brand focused on patented cooking and BBQ-related products, with Earth Science Tech holding an 80% interest.

Through this portfolio, Earth Science Tech combines healthcare services, pharmaceutical manufacturing through compounding, telemedicine infrastructure, real estate support, and consumer brands under a single holding company framework.

Stock and Regulatory Filings

Earth Science Tech’s common stock is registered under Section 12(g) of the Securities Exchange Act of 1934, according to its 8-K filings, and trades under the symbol ETST on the Over the Counter Bulletin Board. The company files periodic and current reports with the SEC, including 8-K filings describing material events such as amendments to its articles of incorporation, regulatory milestones, and press releases related to operations and strategy.

Key Takeaways for ETST Stock

For those researching ETST stock or asking “what is Earth Science Tech, Inc.?”, the company describes itself as:

  • A Florida corporation operating as a strategic holding company.
  • Formally classified under SIC 2834 for pharmaceutical preparations, with a focus on healthcare and pharmaceutical sectors.
  • Managing a portfolio that includes compounding pharmacies, telemedicine platforms, a healthcare facility, real estate development, and a direct-to-consumer brand built on patents and intellectual property.

All of these points are drawn from the company’s own news releases and SEC filings, which together outline Earth Science Tech’s current identity and operational focus.

Stock Performance

$0.0911
+0.00%
+0.00
Last updated: October 2, 2026 at 09:30
-50.8%
Performance 1 year
$26.2M

EARTH SCIENCE TECH (ETST) closed at $0.0911 on October 2, 2026. Over the past 12 months, the price has lost 50.8%.

See what a $1,000 investment in ETST would be worth today

ETST Metrics & Rankings

Price returns through October 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

EARTH SCIENCE TECH has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings. View all ETST news →

Financial Highlights

EARTH SCIENCE TECH generated $35.7M in revenue in FY2026, retaining a 71.4% gross margin, and net income was $3.6M, reflecting a 10.2% net profit margin. Diluted earnings per share stood at $0.01. The company generated $1.9M in operating cash flow. The current ratio was 1.93, measuring current assets divided by current liabilities.

$35.7M
Revenue (FY2026)
$3.6M
Net Income (FY2026)
$1.9M
Operating Cash Flow

Upcoming Events

AUG
31
August 31, 2027 Stock Split

Reverse Split Authorization Expiry

Authorization to effect a board‑discretionary reverse stock split expires 12 months after Aug 31, 2026; could affect uplisting/minimum bid.
DEC
31
December 31, 2027 Financial

Repurchase program expires

Share repurchase authorization extended through December 31 2027
DEC
31
December 31, 2028 Regulatory

Sterile Compounding Certification

Targeted full regulatory certification for sterile compounding by 2028-12-31; Earth Science Tech upgrades Meduvo La Verne, CA facility.

EARTH SCIENCE TECH has 3 upcoming scheduled events. The next event, "Reverse Split Authorization Expiry", is scheduled for August 31, 2027 (in 330 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the ETST stock price.

Short Interest History

Last 12 Months

Short interest in EARTH SCIENCE TECH (ETST) currently stands at 206 shares, down 99.6% from the previous reporting period, representing 0.0% of the float. Since January 2026, short interest has decreased by 98.2%.

Days to Cover History

Last 12 Months

Days to cover for EARTH SCIENCE TECH (ETST) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

ETST Company Profile & Sector Positioning

EARTH SCIENCE TECH (ETST) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing ETST often look at related companies in the same sector, including MARIMED INC (MRMD), VEXT SCIENCE INC (VEXTF), DIGITAL UTIL VNTRS INC (DUTV), THE CANNABIST CO HLDG (CBSTF), and DECIBEL CANNABIS CO (DBCCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ETST's relative position within its industry.

Frequently Asked Questions

What is the current stock price of EARTH SCIENCE TECH (ETST)?

The current stock price of EARTH SCIENCE TECH (ETST) is $0.0911 as of October 2, 2026.

What is the market cap of EARTH SCIENCE TECH (ETST)?

The market cap of EARTH SCIENCE TECH (ETST) is approximately $26.2M. Learn more about what market capitalization means .

What is the revenue of EARTH SCIENCE TECH (ETST) stock?

The FY2026 revenue of EARTH SCIENCE TECH (ETST) is $35.7M, from its most recent completed fiscal year.

What is the net income of EARTH SCIENCE TECH (ETST)?

The FY2026 net income of EARTH SCIENCE TECH (ETST) is $3.6M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of EARTH SCIENCE TECH (ETST)?

The diluted earnings per share (EPS) of EARTH SCIENCE TECH (ETST) is $0.01 for FY2026, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of EARTH SCIENCE TECH (ETST)?

The operating cash flow of EARTH SCIENCE TECH (ETST) is $1.9M. Learn about cash flow.

What is the profit margin of EARTH SCIENCE TECH (ETST)?

The net profit margin of EARTH SCIENCE TECH (ETST) is 10.2%. Learn about profit margins.

What is the gross margin of EARTH SCIENCE TECH (ETST)?

The gross profit margin of EARTH SCIENCE TECH (ETST) is 71.4%. Learn about gross margins.

What is the current ratio of EARTH SCIENCE TECH (ETST)?

The current ratio of EARTH SCIENCE TECH (ETST) is 1.93, measuring current assets divided by current liabilities. Learn about liquidity ratios.

What is the gross profit of EARTH SCIENCE TECH (ETST)?

The gross profit of EARTH SCIENCE TECH (ETST) is $25.5M for FY2026, its most recent completed fiscal year.

What does Earth Science Tech, Inc. (ETST) do?

Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of operating businesses. According to its disclosures, its current operations include compounding pharmaceuticals, telemedicine, real estate development, and consumer brands through subsidiaries such as RxCompoundStore.com, Mister Meds, Peaks Curative, Avenvi, Las Villas Health Care, DOConsultations, Earth Science Foundation, and an 80% interest in MagneChef.

How is Earth Science Tech classified from an industry perspective?

The company states that its primary SIC code is 2834, which corresponds to Pharmaceutical Preparations. It has formally identified itself as a pharmaceutical entity since 2022 and has directed financial data providers to remove outdated CBD or cannabis classifications and reflect its healthcare and pharmaceutical focus.

Where does Earth Science Tech, Inc. trade and under what symbol?

Earth Science Tech, Inc.’s common stock, with a par value of $0.001, is registered under Section 12(g) of the Securities Exchange Act of 1934 and trades on the Over the Counter Bulletin Board under the ticker symbol ETST, as disclosed in its SEC filings.

What role does Avenvi, LLC play within Earth Science Tech’s structure?

Avenvi, LLC is described as a diversified real estate company engaged in development, asset management, and financing. It manages a growing portfolio of real estate holdings, provides turnkey solutions from development to end-user financing, manages investment activities for Earth Science Tech, and oversees the company’s share repurchase program. Avenvi also owns the real estate where Mister Meds operates.

Has Earth Science Tech taken any actions regarding its share structure?

Yes. According to an 8-K filing, Earth Science Tech amended its Articles of Incorporation in Florida to reduce its authorized common stock from 350,000,000 shares to 300,000,000 shares. The amendment was approved via majority shareholder written consent and a corporate resolution. The company has also implemented a common stock repurchase program managed through Avenvi.

What regulatory milestones has Earth Science Tech reported?

Earth Science Tech has reported that FINRA processed a Form 211 relating to the initiation of priced quotations for ETST, which the company describes as an important step in its strategic plan. It has also announced qualification for and listing on the OTCID tier of the OTC Markets, a tier that recognizes companies meeting enhanced disclosure and transparency standards.

How does Earth Science Tech describe its business strategy?

The company describes its strategy as acquiring and scaling high-potential operating businesses, then focusing on operational optimization and long-term value creation. It emphasizes governance improvements, cross-subsidiary coordination, and targeted efficiencies across its portfolio, particularly in its healthcare, telemedicine, real estate, and consumer brand operations.